Brightsurf Science News & Current Events

June 17, 2003
Injection prevents blinding blood vessel growth in mice
Researchers at Johns Hopkins' Wilmer Eye Institute and Regeneron Pharmaceuticals have identified an experimental medicine that stops the blinding blood vessel growth associated with diabetic eye diseases and possibly macular degeneration in laboratory mice.

American Thoracic Society Journal news tips for June 2003 (second issue)
Newsworthy journal articles include studies that show: a single dose of humanized anti-human interleukin-5 antibody given to patients with severe, persistent asthma significantly reduced a white cell blood marker of serious allergic disorders called eosinophils; and elderly nursing home patients who had severe aspiration pneumonia probably suffered from microorganisms colonized in either their dental plaque or oropharyngeal cavity at the time of aspiration.

Insulin-resistance-fighting drug continues to protect against type 2 diabetes
Administering a commonly available drug to lower insulin resistance in women who are at high risk for type 2 diabetes appears to prevent onset of the disease.

Hebrew University researcher studies 'reorganization' of brain in blind people
Studies indicate that congenitally blind (blind from birth) people have superior verbal memory abilities than the sighted.

Active control system could halt squealing brakes in cars, trucks and buses
Squealing brakes cost auto manufacturers several hundred million dollars a year in warranty repairs and are among consumers' top 20 vehicle complaints - even in luxury cars.

Restoring protein expression may slow the spread of prostate cancer
A new study has found that restoring the expression of a protein called RKIP in metastatic prostate cancer cells is associated with decreased cell invasion in vitro, fewer lung metastases in vivo, and reduced vascular invasion in the primary tumor.

Scientists say 'save our seas'
Humans are posing some of the biggest threats yet to Europe's marine environment, according to leading scientists with the marine advisory body--the International Council for the Exploration of the Sea (ICES)--who have compiled the first ever report covering all of the continent's seas.

Is there an unexpected price for late night high tech excitement?
The bright computer display screen contributes to metaltonin suppression, which has been blamed for the tendency to insomnia in the elderly.

The area where carcinogens settle may be a key factor in developing lung cancer
The location of such cancerous lesions in the bronchial airway may not be a random process.

Study supports lengthening prostate cancer screening interval
A new study estimates that one half of the cancers detected by an annual screening program for prostate cancer among men between the ages of 55 and 67 would not have been diagnosed in the absence of screening during the patients' lifetimes, a phenomenon known as overdetection.

Organelle's discovery challenges theory, could alter approach to disease treatment
Researchers looking inside a pathogenic soil bacterium have found an organelle, a subcellular pouch, existing independently from the plasma membrane.

Understanding and treating severely traumatized patients
The Journal of the American Psychoanalytic Association (JAPA) is about to release its summer volume.

New way to make realistic shadows for computer images, animation
Scientists and computer gamers alike could benefit from a new method for creating soft, realistic shadows in computer-generated images.

ESA welcomes setting-up of Galileo Joint Undertaking
The appointment of Rainer Grohe as Director of the Galileo Joint Undertaking marks a further key step forward for Galileo, the first civil global satellite navigation programme.

University of Rhode Island launches Teacher Research and Mentoring Armada
The URI Office of Marine Programs at the Graduate School of Oceanography has received a $2 million grant from the National Science Foundation to establish a five-year national program, the ARMADA Project, to involve K-12 teachers in active ocean science research and mentoring experiences.

Successful design review: ATV gets go-ahead
In early June 2003, the Automated Transfer Vehicle (ATV) programme reached a milestone in successfully passing the Critical Design Review (CDR) during which some 140 international space experts expressed their full confidence in the design of the vehicle after analysing 55,000 pages of technical documentation.

IUB scientists to study the ecology of infectious disease -- inside ticks
Indiana University Bloomington and Ball State University biologists have been awarded $1.88 million by the National Science Foundation and National Institutes of Health to study how harmless and disease-causing microorganisms interact inside the bodies of ticks.

Critical Therapeutics launches Phase I clinical trial of anti-inflammatory compound
Critical Therapeutics, Inc. of Cambridge has launched a Phase I human study to evaluate the safety and tolerability of the company's anti-inflammatory compound CTI-01.

Scientists find protein that controls prostate cancer's spread
Cancer specialists know that it's not usually prostate cancer itself that kills - it's the spread of the cancer from the prostate to the rest of the body.

Millions of Americans suffer from major depression
Millions of Americans suffer from major depression each year, and most are not getting proper treatment for this debilitating disorder, according to a two-year nationwide study reported in the June 18 Journal of the American Medical Association.

Genetic engineering accelerates the impact of biotechnology on chemical production
Biotechnology advances are producing results in the production of commodity chemicals, such as ethanol, and specialty chemicals, such as pharmaceuticals and nutrients.

Following heart attacks, treatment helps depression but does not prevent future attacks, study finds
Following heart attacks, cognitive behavior therapy can help depressed patients and those lacking support from family and friends but will not cut their risk of having another attack or postpone death, a major multi-center study concludes.

The mechanical switch in the ear
Max Planck scientists have discovered the elusive channel that converts mechanical energy into electrical signals in sensory hair cells.

Medication may slow progression of Alzheimer disease
A medication used to treat the symptoms of mild-to-moderate Alzheimer disease may delay progression of the disorder, according to an Indiana University School of Medicine study.

CRDF presents on Russian biotechnology at Biotechnology Industry Organization's annual meeting
The U.S. Civilian Research and Development Foundation is presenting two seminars at the Biotechnology Industry Organization's annual meeting.

UK research, accessible for free, for everyone
More than 80,000 biology and medical researchers working at UK universities can now share their research findings freely with fellow researchers, funding bodies, students, journalists, and the general public worldwide.

'Man's best friend' may be even better
The beagle dog proves to be an effective companion in the study of human allergies.

Treatment for depression in heart attack patients fails to improve survival
A team of researchers from Washington University School of Medicine in St.

In vitro study suggests acrylamide causes DNA damage
Acrylamide, a possible human carcinogen that has been found in a variety of fried and starch-based foods, appears to exert its mutagenicity (the capacity to induce mutations) by forming DNA adducts and introducing genetic mutations, according to a study in the June 18 issue of the Journal of the National Cancer Institute. DNA adducts can interfere with the DNA replication process and lead to mutations and, in theory, to tumor formation.

No survival benefit for heart disease patients treated for depression and low social support
The first major study to evaluate the effects of treating depression and low social support in recent heart attack patients found no reduction in deaths or second heart attacks; however, study participants showed significant improvement in depression and social functioning.

Other highlights of the June 18 JNCI
Other highlights in the June 18 issue of JNCI include a study examining the association between isoflavone consumption and risk of breast cancer, a study finding that the vitamin D analog paricalcitol may be effective against a variety of cancers, and a study finding no association between colorectal cancer and diets high in carbohydrates or sugar.

Stanford research finds better results in newer antipsychotic meds
Nearly 5 million people in the United States suffer from schizophrenia or manic depression, making antipsychotics the fourth-highest selling class of drugs.

Muscle protein has role in nerve disorders
A protein that plays a role in muscular dystrophies also may be involved in peripheral neuropathy - disorders of the nerves that carry messages between the brain and the rest of the body.

Eye movement studies to help diagnose mental illness
Researchers at the University of Illinois at Chicago are studying subtle abnormalities in eye movements that may one day be used to diagnose psychiatric disease.

Mayo Clinic researchers discover new immune system molecule that can help or harm health
Mayo Clinic researchers have identified a new member of the important B7 family of immune system

Pakistani injection drug users twice as likely to donate blood
Pakistani injection drug users are paid to donate blood, which could contaminate the global blood supply and increase the spread of HIV/AIDS and hepatitis B and C.

Producing 6000 million coins for the introduction of the euro
COINBLANK created the most advanced facility in the world to produce coin blanks in preparation for the euro.

Stanford study shows drug for treating type-2 diabetes may limit heart disease risk
A drug used to treat high blood sugar in people with type-2 diabetes also may lower the risk of cardiovascular disease, according to research at Stanford University Medical Center.

New findings suggest colorectal cancer origins are different than previously thought
A study discovers that what was thought to be the primary indicator of the beginings colorectal cancer is really a secondary phenomenon.

Laboratory to unveil new licensed technology
The Laboratory will unveil its latest cutting-edge technology for rapid detection and identification of radioactive material during a special ceremony.
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.